Onconetix (ONCO) Current Leases (2023 - 2026)
Onconetix (ONCO) posted quarterly Current Leases of $24415.0 for Q1 2026, down 72.81% year-over-year from $89808.0 in Q1 2025, and little changed quarter-over-quarter from $24412.0 in Q4 2025.
Onconetix (ONCO) Current Leases (2023 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Current Leases for 4 consecutive years, with $24415.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 72.81% year-over-year to $24415.0; the TTM figure through Mar 2026 stood at $24415.0 (down 72.81% YoY), while the FY2025 annual figure was $24412.0, down 79.56% from the prior year.
- Current Leases steadied at $24415.0 in Q1 2026 per ONCO's latest filing, from $24412.0 in the prior quarter.
- Across five years, Current Leases topped out at $127738.0 in Q3 2024 and bottomed at $6155.0 in Q3 2025.
- Historically, Current Leases has averaged $66956.1 across 4 years, with a median of $68366.0 in 2023.
- Annual changes were most pronounced in 2024 — Current Leases surged 60.84% — and 2025, when it slumped 95.18%.
- Onconetix's Current Leases stood at $74252.0 in 2023, then soared by 60.84% to $119427.0 in 2024, then sank by 79.56% to $24412.0 in 2025, then advanced by 0.01% to $24415.0 in 2026.
- Business Quant data shows ONCO's Current Leases at $24415.0 in Q1 2026, $24412.0 in Q4 2025, and $6155.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | 24,419.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24,419.00 |
| Mar 31, 2026 | 24,415.00 |
| Dec 31, 2025 | 24,412.00 |
| Sep 30, 2025 | 6,155.00 |
| Jun 30, 2025 | 21,400.00 |
| Mar 31, 2025 | 89,808.00 |
| Dec 31, 2024 | 119,427.00 |
| Sep 30, 2024 | 127,738.00 |
| Jun 30, 2024 | 119,474.00 |
| Mar 31, 2024 | 62,480.00 |
| Dec 31, 2023 | 74,252.00 |